Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from ...
Management to host conference call and webcast this morning at 8:30 a.m. EDT Jenrin’s extensive pipeline positions Corbus to be a leader in the treatment of inflammatory and fibrotic diseases with small molecules specifically designed to target the …